Literature DB >> 7138773

Cellular immune function study in an ovarian cancer-prone kindred.

G S Schuelke, H T Lynch, J F Lynch, E A Chaperon, J A Recabaren, B Grabner, W A Albano.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 7138773      PMCID: PMC2011189          DOI: 10.1038/bjc.1982.256

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  24 in total

1.  Circulating antibodies in patients with ovarian carcinoma.

Authors:  M A Gerber; D Koffler; C J Cohen
Journal:  Gynecol Oncol       Date:  1977-09       Impact factor: 5.482

2.  Immunosuppressive effect of serum in patients with ovarian carcinoma.

Authors:  K Ueda; M Toyokawa; H Nakamori; H Sako; N Umesaki; J Nakade; T Lee; T Sugawa
Journal:  Obstet Gynecol       Date:  1978-02       Impact factor: 7.661

3.  Immune complexes in ovarian cancer.

Authors:  T A Poulton; M E Crowther; F C Hay; L J Nineham
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

4.  Sensitisation of neuroblastoma patients and related and unrelated contacts to neuroblastoma extracts.

Authors:  J Graham-Pole; L J Ogg; C E Ross; A J Cochran
Journal:  Lancet       Date:  1976-06-26       Impact factor: 79.321

5.  Serum concentrations of G, A, and M immunoglobulins in patients with carcinoma, melanoma, and sarcoma.

Authors:  N R Hughes
Journal:  J Natl Cancer Inst       Date:  1971-05       Impact factor: 13.506

6.  Genetic and communicable effects on carcinoembryonic antigen expressivity in the cancer family syndrome.

Authors:  H A Guirgis; H T Lynch; R E Harris; J P Vandevoorde
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

7.  Role of tumor immunity in ovarian cancer.

Authors:  L Humphrey; D Panoussopoulos; F J Volenec; B J Masterson; W Jewell
Journal:  South Med J       Date:  1977-10       Impact factor: 0.954

8.  Expression of cell-mediated immunity and blocking factor using a new line of ovarian cancer cells in vitro.

Authors:  R A Pattillo; M T Story; A C Ruckert
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

9.  Tumor-specific cell-mediated immunity in household contacts of cancer patients..

Authors:  V S Byers; A S Levin; A J Hackett; H H Fudenberg
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

10.  Inhibition of effector cell function in human antibody-dependent cellular cytotoxicity by sera from cancer patients.

Authors:  S M Mikulski; R Billing; P I Terasaki
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.